Literature DB >> 25140059

The 25-year genetic era in hypertrophic cardiomyopathy: revisited.

Barry J Maron1, Martin S Maron2.   

Abstract

Entities:  

Keywords:  Editorials; cardiomyopathy, hypertrophic; genetic testing; genomics; heart failure

Mesh：

Year:  2014        PMID： 25140059     DOI： 10.1161/CIRCGENETICS.114.000741

Source DB:  PubMed          Journal:  Circ Cardiovasc Genet        ISSN： 1942-3268


× No keyword cloud information.
  6 in total

1.  Electrocardiographic Characterization of Cardiac Hypertrophy in Mice that Overexpress the ErbB2 Receptor Tyrosine Kinase.

Authors:  Polina Sysa-Shah; Lars L Sørensen; M Roselle Abraham; Kathleen L Gabrielson
Journal:  Comp Med       Date:  2015-08       Impact factor: 0.982

Review 2.  Clinical outcomes associated with sarcomere mutations in hypertrophic cardiomyopathy: a meta-analysis on 7675 individuals.

Authors:  Farbod Sedaghat-Hamedani; Elham Kayvanpour; Oguz Firat Tugrul; Alan Lai; Ali Amr; Jan Haas; Tanja Proctor; Philipp Ehlermann; Katrin Jensen; Hugo A Katus; Benjamin Meder
Journal:  Clin Res Cardiol       Date:  2017-08-24       Impact factor: 5.460

3.  Mavacamten decreases maximal force and Ca2+ sensitivity in the N47K-myosin regulatory light chain mouse model of hypertrophic cardiomyopathy.

Authors:  Peter O Awinda; Marissa Watanabe; Yemeserach Bishaw; Anna M Huckabee; Keinan B Agonias; Katarzyna Kazmierczak; Danuta Szczesna-Cordary; Bertrand C W Tanner
Journal:  Am J Physiol Heart Circ Physiol       Date:  2020-12-18       Impact factor: 4.733

Review 4.  Recent Advances in Understanding and Managing Cardiomyopathy.

Authors:  Paulino Alvarez; Wh Wilson Tang
Journal:  F1000Res       Date:  2017-09-07

5.  Divergent effects of adrenaline in human induced pluripotent stem cell-derived cardiomyocytes obtained from hypertrophic cardiomyopathy.

Authors:  Chandra Prajapati; Marisa Ojala; Katriina Aalto-Setälä
Journal:  Dis Model Mech       Date:  2018-02-26       Impact factor: 5.758

6.  Clinical Outcomes in Patients With Nonobstructive, Labile, and Obstructive Hypertrophic Cardiomyopathy.

Authors:  Dai-Yin Lu; Iraklis Pozios; Bereketeab Haileselassie; Ioannis Ventoulis; Hongyun Liu; Lars L Sorensen; Marco Canepa; Susan Phillip; M Roselle Abraham; Theodore P Abraham
Journal:  J Am Heart Assoc       Date:  2018-02-25       Impact factor: 5.501
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.